Portal de Periódicos da CAPES

Phase I Study of Cytokine-Gene Modified Autologous Neuroblastoma Cells for Treatment of Relapse/Refractory Neuroblastoma

1992; Mary Ann Liebert, Inc.; Volume: 3; Issue: 6 Linguagem: Inglês

10.1089/hum.1992.3.6-665

1557-7422

Malcolm K. Brenner, Wayne L. Furman, Victor M. Santana, Laura C. Bowman, William H. Meyer, William M. Crist, Dario Campana, Edwin C. Douglass, James Ihle, James M. Boyett, Julia L. Hurwitz, Bhaskar N. Rao, Jesse J. Jenkins, Barry D. Fletcher, William H. Kaufman, Robert C. Moen, Dan Kuebing,

Neuroblastoma Research and Treatments

Human Gene TherapyVol. 3, No. 6 News and CommentsPhase I Study of Cytokine-Gene Modified Autologous Neuroblastoma Cells for Treatment of Relapse/Refractory NeuroblastomaPRINCIPAL INVESTIGATOR Malcolm K. Brenner, CO-PRINCIPAL INVESTIGATORS Wayne L. Furman, Victor M. Santana, Laura Bowman, William Meyer, CO-INVESTIGATORS William M. Crist, Dario Campana, Edwin C. Douglass, James Ihle, James Boyett, Julia Hurwitz, Bhaskar N. Rao, Jesse J. Jenkins, Barry Fletcher, William Kaufman, Robert Moen, and Dan KuebingPRINCIPAL INVESTIGATOR Malcolm K. BrennerSearch for more papers by this author, CO-PRINCIPAL INVESTIGATORS Wayne L. FurmanSearch for more papers by this author, Victor M. SantanaSearch for more papers by this author, Laura BowmanSearch for more papers by this author, William MeyerSearch for more papers by this author, CO-INVESTIGATORS William M. CristSearch for more papers by this author, Dario CampanaSearch for more papers by this author, Edwin C. DouglassSearch for more papers by this author, James IhleSearch for more papers by this author, James BoyettSearch for more papers by this author, Julia HurwitzSearch for more papers by this author, Bhaskar N. RaoSearch for more papers by this author, Jesse J. JenkinsSearch for more papers by this author, Barry FletcherSearch for more papers by this author, William KaufmanSearch for more papers by this author, Robert MoenSearch for more papers by this author, and Dan KuebingSearch for more papers by this authorPublished Online:13 Jun 2008https://doi.org/10.1089/hum.1992.3.6-665AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byAdenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma23 December 2015 | Oncotarget, Vol. 7, No. 4Current status of local therapy in malignant gliomas — A clinical review of three selected approachesPharmacology & Therapeutics, Vol. 139, No. 3A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiformeWorld Journal of Experimental Medicine, Vol. 1, No. 1Apport des biothérapies anticancéreuses dans le traitement des leucémies de l’enfantArchives de Pédiatrie, Vol. 9, No. 3CANCER VACCINESHematology/Oncology Clinics of North America, Vol. 15, No. 4Gene therapy for paediatric leukaemia23 February 2005 | Expert Opinion on Biological Therapy, Vol. 1, No. 4Viral Vectors for Gene TransferDrugs, Vol. 60, No. 2Clinical Protocol: Phase I Study of Chemokine and Cytokine Gene-Modified Autologous Neuroblastoma Cells for Treatment of Relapsed/Refractory Neuroblastoma Using an Adenoviral Vector.6 July 2004 | Human Gene Therapy, Vol. 11, No. 10Autoimmune disease induced by dendritic cell immunization against leukemiaLeukemia Research, Vol. 23, No. 6IL-2 Adenovector-Transduced Autologous Tumor Cells Induce Antitumor Immune Responses in Patients With NeuroblastomaBlood, Vol. 92, No. 6Interleukin-2 Gene-Modified Allogeneic Tumor Cells for Treatment of Relapsed Neuroblastoma Laura C. Bowman, Michael Grossmann, Donna Rill, Michael Brown, Wan-Yun Zhong, Barbara Alexander, Thasia Leimig, Elaine Coustan-Smith, Dario Campana, Jesse Jenkins, Diane Woods, and Malcolm Brenner20 March 2008 | Human Gene Therapy, Vol. 9, No. 9Gene and Cell Transfer for Specific Immunotherapy9 August 2011 | Vox Sanguinis, Vol. 74, No. S2CD40 Ligand Induces an Antileukemia Immune Response In VivoBlood, Vol. 90, No. 5Genetic Staging of Unresectable or Metastatic Neuroblastomain Infants: a Pediatric Oncology Group StudyJNCI Journal of the National Cancer Institute, Vol. 89, No. 5Methoden der GenübertragungGene therapy in surgeryEuropean Surgery, Vol. 29, No. 1Cytokine Gene Transduction in the Immunotherapy of CancerGene therapy in pediatric oncologyInvestigational New Drugs, Vol. 14, No. 1Cytokines and clinical gene therapyEuropean Journal of Immunology, Vol. 25, No. 4Gene transfer and cancer chemotherapyGene therapy in the treatment of diseaseJournal of Allergy and Clinical Immunology, Vol. 94, No. 6Neuroblastoma stage Iv-SMedical Oncology, Vol. 11, No. 3-4Gene therapy for cancerTrends in Genetics, Vol. 10, No. 57 Cytokine gene transfer in the therapy of malignancyBaillière's Clinical Haematology, Vol. 7, No. 1Retrovirus-mediated gene transfer in cancer therapyPharmacology & Therapeutics, Vol. 63, No. 3Clinical application of immunostimulatory gene transferEuropean Journal of Cancer, Vol. 30, No. 8Neuroblastoma: The result of multistep transformation?23 December 2008 | STEM CELLS, Vol. 11, No. 4 Volume 3Issue 6Dec 1992 To cite this article:PRINCIPAL INVESTIGATOR Malcolm K. Brenner, CO-PRINCIPAL INVESTIGATORS Wayne L. Furman, Victor M. Santana, Laura Bowman, William Meyer, CO-INVESTIGATORS William M. Crist, Dario Campana, Edwin C. Douglass, James Ihle, James Boyett, Julia Hurwitz, Bhaskar N. Rao, Jesse J. Jenkins, Barry Fletcher, William Kaufman, Robert Moen, and Dan Kuebing.Phase I Study of Cytokine-Gene Modified Autologous Neuroblastoma Cells for Treatment of Relapse/Refractory Neuroblastoma.Human Gene Therapy.Dec 1992.665-676.http://doi.org/10.1089/hum.1992.3.6-665Published in Volume: 3 Issue 6: June 13, 2008PDF download